AbCelex Technologies
Mississauga
About AbCelex Technologies
AbCelex Technologies is a biotechnology company that develops solutions which focus on animal health and food safety challenges. It focuses on swine, poultry, and other farm animals. AbCelex Technologies develops protein feed that is able to prevent and treat a number of bacterial infections in animals. It offers NF-220, sdAb-based protein fragments. AbCelex Technologies was founded by Saeid Babaei in 2010. It is based in Mississauga, Ontario.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.0M
- Funding stage: Early Stage Venture
- Last round: Non-Equity Assistance (Feb 2021)
- Website: abcelex.com
- Phone: (647) 494-8787
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/abcelex-technologies-2733110 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.